CN1733763A - 巴马亭及其盐类的合成工艺 - Google Patents
巴马亭及其盐类的合成工艺 Download PDFInfo
- Publication number
- CN1733763A CN1733763A CN 200510060266 CN200510060266A CN1733763A CN 1733763 A CN1733763 A CN 1733763A CN 200510060266 CN200510060266 CN 200510060266 CN 200510060266 A CN200510060266 A CN 200510060266A CN 1733763 A CN1733763 A CN 1733763A
- Authority
- CN
- China
- Prior art keywords
- palmatine
- veratrole
- reaction
- add
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 title claims abstract description 65
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 title claims abstract description 51
- 238000000034 method Methods 0.000 title claims abstract description 7
- 150000003839 salts Chemical class 0.000 title abstract description 10
- 230000015572 biosynthetic process Effects 0.000 title abstract description 6
- 230000008569 process Effects 0.000 title abstract description 4
- 238000003786 synthesis reaction Methods 0.000 title abstract description 4
- ABDKAPXRBAPSQN-UHFFFAOYSA-N veratrole Chemical compound COC1=CC=CC=C1OC ABDKAPXRBAPSQN-UHFFFAOYSA-N 0.000 claims abstract description 69
- 238000002360 preparation method Methods 0.000 claims abstract description 18
- 239000002253 acid Substances 0.000 claims abstract description 11
- 238000009833 condensation Methods 0.000 claims abstract description 10
- 230000005494 condensation Effects 0.000 claims abstract description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 54
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 36
- 238000006243 chemical reaction Methods 0.000 claims description 36
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 26
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims description 22
- BJMYMSQUKAJMJW-UHFFFAOYSA-N C(C)#N.COC1=C(C=CC=C1)OC Chemical compound C(C)#N.COC1=C(C=CC=C1)OC BJMYMSQUKAJMJW-UHFFFAOYSA-N 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 21
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 18
- 229910052739 hydrogen Inorganic materials 0.000 claims description 17
- 239000001257 hydrogen Substances 0.000 claims description 15
- 229910021529 ammonia Inorganic materials 0.000 claims description 13
- 239000003054 catalyst Substances 0.000 claims description 12
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000009413 insulation Methods 0.000 claims description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 238000005984 hydrogenation reaction Methods 0.000 claims description 8
- -1 bromo 4-butyl Chemical group 0.000 claims description 7
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical group C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 claims description 6
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 claims description 6
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 claims description 6
- 229940073608 benzyl chloride Drugs 0.000 claims description 6
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 claims description 6
- 229960003280 cupric chloride Drugs 0.000 claims description 6
- 150000004678 hydrides Chemical class 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 claims description 6
- 238000010792 warming Methods 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 5
- 150000002431 hydrogen Chemical class 0.000 claims description 5
- 239000003444 phase transfer catalyst Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- OQMUXQPCUBYTEB-UHFFFAOYSA-N benzene-1,2-diol;sodium Chemical compound [Na].OC1=CC=CC=C1O OQMUXQPCUBYTEB-UHFFFAOYSA-N 0.000 claims description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 4
- 230000008025 crystallization Effects 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- DBKUBQGEHGTBPO-UHFFFAOYSA-N ClCC(=O)OC(CCl)=O.[Na] Chemical compound ClCC(=O)OC(CCl)=O.[Na] DBKUBQGEHGTBPO-UHFFFAOYSA-N 0.000 claims description 3
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 3
- 238000006482 condensation reaction Methods 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 claims description 3
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 238000000199 molecular distillation Methods 0.000 claims description 2
- 230000000630 rising effect Effects 0.000 claims description 2
- 238000010189 synthetic method Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims 1
- FIZCECVCBFVQNX-UHFFFAOYSA-N 2-(1,6-dimethoxycyclohexa-2,4-dien-1-yl)ethanamine Chemical compound COC1(C(C=CC=C1)OC)CCN FIZCECVCBFVQNX-UHFFFAOYSA-N 0.000 abstract 1
- ZAWRHMKNNDMOTG-UHFFFAOYSA-N acetonitrile 1,3-benzodioxole Chemical compound C(C)#N.C1OC2=C(C=CC=C2)O1 ZAWRHMKNNDMOTG-UHFFFAOYSA-N 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 238000006266 etherification reaction Methods 0.000 abstract 1
- RLQYRXCUPVKSAW-UHFFFAOYSA-M 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium;chloride Chemical compound [Cl-].COC1=C(OC)C=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=C1 RLQYRXCUPVKSAW-UHFFFAOYSA-M 0.000 description 37
- RIDQRIPSFYHEGL-UHFFFAOYSA-N fibrauretin Natural products CC12CC=C3C(=O)OC(CC3(C)C1C(=O)C=CC2=O)c4cocc4 RIDQRIPSFYHEGL-UHFFFAOYSA-N 0.000 description 31
- 229930014626 natural product Natural products 0.000 description 16
- 230000000242 pagocytic effect Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 8
- 210000000265 leukocyte Anatomy 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 230000003260 anti-sepsis Effects 0.000 description 6
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 239000012065 filter cake Substances 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000003385 bacteriostatic effect Effects 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 241000194017 Streptococcus Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000002262 Schiff base Substances 0.000 description 2
- 150000004753 Schiff bases Chemical class 0.000 description 2
- 241000607762 Shigella flexneri Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 240000006464 Fibraurea tinctoria Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- TUCIXUDAQRPDCG-UHFFFAOYSA-N benzene-1,2-diol Chemical compound OC1=CC=CC=C1O.OC1=CC=CC=C1O TUCIXUDAQRPDCG-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000007265 chloromethylation reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000009183 running Effects 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000004148 unit process Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
样品 | 样品含量、鉴别 | ||||
1月 | 3月 | 6月 | 12月 | 24月 | |
实施例1 | 合格 | 合格 | 合格 | / | / |
实施例2 | 合格 | 合格 | 合格 | / | / |
实施例3 | 合格 | 合格 | 合格 | 合格 | 合格 |
实施例4 | 合格 | 合格 | 合格 | 合格 | 合格 |
实施例5 | 合格 | 合格 | 合格 | 合格 | 合格 |
实施例6 | 合格 | 合格 | 合格 | 合格 | 合格 |
抗菌作用/品名 | 合成品 | 天然品 | |
金葡菌犬小孢子菌白色念珠菌卡尔酵母菌酸性分枝杆菌痢疾杆菌大肠杆菌乙型链球菌亚洲甲型流感病毒宋内氏痢疾杆菌白色葡萄球菌柠檬色葡萄球菌副大肠杆菌对福氏痢疾杆菌金黄色葡萄球菌乙型链球菌对福氏痢疾杆菌金黄色葡萄球菌乙型链球菌大肠杆菌 | 1.08cm(0.05%浓度下)500μg/ml250μg/ml(+)500μg/ml1000μg/ml1000μg/ml1000μg/ml1000μg/ml1000μg/ml0.86%(+++)0.86%(+++)0.86%(+++)0.86%(+++)0.645%(+++)0.645%(+++)0.645%(+++)0.43%(++)0.43%(++)0.43%(++)0.43%(++) | 1.06cm(0.05%浓度下)(+)250μg/ml(+)(+)(+)(+)(+)(+)(+)0.86%(+++)0.86%(+++)0.86%(+++)0.86%(+++)0.645%(+++)0.645%(+++)0.645%(+++)0.43%(++)0.43%(++)0.43%(++)0.43%(++) | 500μg/ml(+)500μg/ml(+)1000μg/ml(+)1000μg/ml(+)1000μg/ml(+)1000μg/ml(+)1000μg/ml(+) |
药物 | 剂量 | 动物数 | 吞噬数 | 显著性测验 |
生理盐水合成品天然品 | 0.1ml/kg 共2次15mg/kg 共2次15mg/kg 共2次 | 253030 | 27.4±1.3442.5±1.3741.7±1.36 | P<0.001P<0.001 |
合成组 | 天然组 | 对照组 | |||
兔号 | 刚果红指数 | 兔号 | 刚果红指数 | 兔号 | 刚果红指数 |
1234567891011 | 35.730.445.932.546.126.841.326.453.944.455.1 | 1314151617181920212223 | 35.630.943.528.932.556.155.328.435.943.649.0 | 2526272829303132333435 | 39.2/34.145.435.736.734.635.930.539.226 |
12平均值 | 47.740.5±2.88 | 24平均值 | 30.739.2±3.59 | 36平均值 | 34.141.7±4.69 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100602666A CN100526311C (zh) | 2005-08-02 | 2005-08-02 | 巴马亭的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100602666A CN100526311C (zh) | 2005-08-02 | 2005-08-02 | 巴马亭的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1733763A true CN1733763A (zh) | 2006-02-15 |
CN100526311C CN100526311C (zh) | 2009-08-12 |
Family
ID=36076405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100602666A Expired - Fee Related CN100526311C (zh) | 2005-08-02 | 2005-08-02 | 巴马亭的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100526311C (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102408424A (zh) * | 2011-09-28 | 2012-04-11 | 长春工业大学 | 一种用具有异喹啉结构的黄连混合生物总碱制备巴马汀的方法 |
CN102532130A (zh) * | 2011-12-27 | 2012-07-04 | 广西中医学院 | 抗菌消炎药黄藤素的全化学合成方法 |
CN102786518A (zh) * | 2011-05-18 | 2012-11-21 | 中国医学科学院药物研究所 | 盐酸巴马汀晶b型物质及制法与在药品和保健品中应用 |
CN102993198A (zh) * | 2011-09-15 | 2013-03-27 | 上海壹志医药科技有限公司 | 用于制备三种异喹啉生物碱或其盐的三种新中间体及其制备方法、三种异喹啉生物碱或其盐的制备方法 |
CN103012170A (zh) * | 2012-11-29 | 2013-04-03 | 张家港市大伟助剂有限公司 | 一种4-甲氧基苯乙胺的制备方法 |
CN104016978A (zh) * | 2014-06-06 | 2014-09-03 | 北京健坤和医药科技有限公司 | 盐酸巴马汀晶c型、其的制备方法以及其在药物组合物或保健品中的用途 |
CN104513225A (zh) * | 2013-10-08 | 2015-04-15 | 华东师范大学 | 2-噻吩乙腈的制备方法 |
CN105384650A (zh) * | 2014-09-09 | 2016-03-09 | 中国石油化工股份有限公司 | 一种3,4-二甲氧基苯乙胺生产技术 |
CN108358913A (zh) * | 2018-02-28 | 2018-08-03 | 四川依科制药有限公司 | 一种硫酸罗通定的绿色合成工艺 |
-
2005
- 2005-08-02 CN CNB2005100602666A patent/CN100526311C/zh not_active Expired - Fee Related
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102786518A (zh) * | 2011-05-18 | 2012-11-21 | 中国医学科学院药物研究所 | 盐酸巴马汀晶b型物质及制法与在药品和保健品中应用 |
CN102786518B (zh) * | 2011-05-18 | 2016-09-14 | 中国医学科学院药物研究所 | 盐酸巴马汀晶b型物质及制法与在药品和保健品中应用 |
CN102993198A (zh) * | 2011-09-15 | 2013-03-27 | 上海壹志医药科技有限公司 | 用于制备三种异喹啉生物碱或其盐的三种新中间体及其制备方法、三种异喹啉生物碱或其盐的制备方法 |
CN102408424A (zh) * | 2011-09-28 | 2012-04-11 | 长春工业大学 | 一种用具有异喹啉结构的黄连混合生物总碱制备巴马汀的方法 |
CN102532130A (zh) * | 2011-12-27 | 2012-07-04 | 广西中医学院 | 抗菌消炎药黄藤素的全化学合成方法 |
CN103012170A (zh) * | 2012-11-29 | 2013-04-03 | 张家港市大伟助剂有限公司 | 一种4-甲氧基苯乙胺的制备方法 |
CN104513225A (zh) * | 2013-10-08 | 2015-04-15 | 华东师范大学 | 2-噻吩乙腈的制备方法 |
CN104016978A (zh) * | 2014-06-06 | 2014-09-03 | 北京健坤和医药科技有限公司 | 盐酸巴马汀晶c型、其的制备方法以及其在药物组合物或保健品中的用途 |
CN105384650A (zh) * | 2014-09-09 | 2016-03-09 | 中国石油化工股份有限公司 | 一种3,4-二甲氧基苯乙胺生产技术 |
CN105384650B (zh) * | 2014-09-09 | 2017-11-17 | 中国石油化工股份有限公司 | 一种3,4‑二甲氧基苯乙胺生产技术 |
CN108358913A (zh) * | 2018-02-28 | 2018-08-03 | 四川依科制药有限公司 | 一种硫酸罗通定的绿色合成工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN100526311C (zh) | 2009-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1733763A (zh) | 巴马亭及其盐类的合成工艺 | |
CN1257969C (zh) | 头花蓼提取物及其制备方法和用途 | |
CN1730015A (zh) | 金银花提取物及其制备方法和应用 | |
CN101053568A (zh) | 一种复方磺胺间甲氧嘧啶钠注射液的配方及制作工艺 | |
CN1680355A (zh) | 一种治疗慢性咽炎、慢性扁桃体炎的中药有效部位山香园总黄酮的制备方法 | |
CN1219545C (zh) | 头花蓼提取物及其药物组合物制剂 | |
CN1879686A (zh) | 一种治疗禽病毒性疾病的中药组合物及制备方法 | |
CN1686460A (zh) | 一种清开灵输液及其制备方法 | |
CN1273493C (zh) | 一种当归多糖及其制备方法和用途 | |
CN1772272A (zh) | 一种食物抗生素及其制备方法 | |
CN1864666A (zh) | 甲磺酸左氧氟沙星冻干粉针注射剂及其制备方法 | |
CN1732934A (zh) | 注射用盐酸倍他司汀冻干粉针剂及其制备方法 | |
CN1552425A (zh) | 一种金银花提取物及其制剂与用途 | |
CN1297948A (zh) | 一种海藻多糖及其制备方法和用途 | |
CN1528759A (zh) | 柴胡茎叶提取物及其制备方法和用途 | |
CN1267120C (zh) | 一种鱼腥草冻干粉针剂及其制备方法 | |
CN1634413A (zh) | 一种勒马回注射制剂及其制备方法 | |
CN101554405A (zh) | 一种夏桑菊滴丸及其制备方法 | |
CN1291738C (zh) | 一种抗炎抗病毒药物组合物及其制备工艺 | |
CN1283230C (zh) | 一种祖师麻冻干粉针剂及其制备方法 | |
CN1616038A (zh) | 一种野菊花冻干粉针剂及其制备方法 | |
CN1283246C (zh) | 治疗急性胰腺炎的复方大黄素黄芩素注射液、冻干粉针及制备方法 | |
CN1772173A (zh) | 一种食物抗生素及其制备方法 | |
CN1406940A (zh) | 叶绿素铬及其制备方法与用途 | |
CN1067405C (zh) | 硫酸酯化箬叶多糖及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YU JUAN Free format text: FORMER OWNER: ZHEJIANG ZIJIANG BIOTECHNOLOGY CO., LTD. Effective date: 20070817 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070817 Address after: 650100 Yunnan Province, Kunming city Wuhua District Lake Road No. 52 Applicant after: Yu Juan Address before: Hangzhou City, Zhejiang province 310012 No. 18 Moganshan Road Gongshu District sky building 11A Applicant before: Zhejiang Zijiang Biotechnology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090812 Termination date: 20120802 |